The PI3 Kinase Signaling Pathway in Prostate Cancer

Author(s): Aymen A. Elfiky, Zhenyang Jiang

Journal Name: Current Cancer Drug Targets

Volume 13 , Issue 2 , 2013

Become EABM
Become Reviewer


Despite recent advances in our understanding of the biological basis of prostate cancer, the management of the disease, especially in the castration-resistant phase, remains a significant challenge. Deregulation of the phosphatidylinositol 3-kinase (PI3K) pathway is increasingly implicated in a number of malignancies, including prostate carcinogenesis. In this review, we detail the role of this pathway in the pathogenesis of prostate cancer and the therapeutic implications of targeting it.

Keywords: Androgen receptor, mammalian target of rapamycin, phosphatidylinositol 3-kinase, prostate cancer, PTEN.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [157 - 164]
Pages: 8
DOI: 10.2174/1568009611313020005
Price: $65

Article Metrics

PDF: 34